17.48

0.23% 0.04

Seres Therapeutics Inc (MCRB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$17.44

Aprire:

$17.5

Volume 24 ore:

79,869

Relative Volume:

0.36

Capitalizzazione di mercato:

$158.13M

Reddito:

$123.24M

Utile/perdita netta:

$136.00K

Rapporto P/E:

-874.00

EPS:

-0.02

Flusso di cassa netto:

$-148.99M

1 W Prestazione:

+3.62%

1M Prestazione:

+27.13%

6M Prestazione:

+145.16%

1 anno Prestazione:

+6.72%

Intervallo 1D:

$16.80

$17.90

Intervallo di 1 settimana:

$16.61

$18.86

Portata 52W:

$6.53

$29.98

Seres Therapeutics Inc Stock (MCRB) Company Profile

Nome

Seres Therapeutics Inc

Settore

Healthcare (1131)

Industria

Biotechnology (632)

Telefono

617 945 9626

Indirizzo

200 SIDNEY STREET, CAMBRIDGE, MA

Dipendente

103

Cinguettio

@SeresTX

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

MCRB's Discussions on Twitter

Confronta MCRB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MCRB Seres Therapeutics Inc	17.48	157.77M	123.24M	136.00K	-148.99M	-0.02
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-08	Downgrade	Chardan Capital Markets	Buy → Neutral
2024-10-24	Downgrade	JP Morgan	Neutral → Underweight
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-04-21	Iniziato	JP Morgan	Neutral
2021-07-23	Downgrade	Goldman	Neutral → Sell
2021-05-18	Ripresa	Goldman	Neutral
2021-03-05	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2020-09-18	Downgrade	Chardan Capital Markets	Buy → Neutral
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-11	Reiterato	H.C. Wainwright	Buy
2020-08-11	Aggiornamento	Jefferies	Hold → Buy
2019-04-30	Iniziato	Jefferies	Hold
2018-10-22	Iniziato	Chardan Capital Markets	Buy
2017-10-13	Iniziato	Oppenheimer	Outperform
2017-08-04	Reiterato	H.C. Wainwright	Buy
2017-02-01	Reiterato	FBR & Co.	Outperform
2016-08-12	Reiterato	FBR Capital	Outperform
2016-08-01	Downgrade	BofA/Merrill	Buy → Neutral
2016-08-01	Reiterato	H.C. Wainwright	Buy
2016-07-29	Ripresa	H.C. Wainwright	Buy
2016-03-30	Iniziato	FBR Capital	Outperform
2016-03-03	Iniziato	Guggenheim	Buy
2016-01-25	Iniziato	H.C. Wainwright	Buy
2015-10-22	Aggiornamento	BofA/Merrill	Neutral → Buy
2015-07-22	Iniziato	Canaccord Genuity	Buy
2015-07-21	Iniziato	Goldman	Neutral
2015-07-21	Iniziato	Leerink Partners	Outperform

Mostra tutto

Seres Therapeutics Inc Borsa (MCRB) Ultime notizie

04:17 AM

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving AverageHere's What Happened - MarketBeat

04:17 AM

Dec 03, 2025

Will Seres Therapeutics Inc. (1S90) stock outperform foreign stocksWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser

Dec 03, 2025

Will Seres Therapeutics Inc. (1S90) stock beat value stocks2025 Year in Review & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Dec 02, 2025

What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock2025 Institutional Moves & Free Daily Entry Point Trade Alerts - Newser

Dec 02, 2025

What risks investors should watch in Seres Therapeutics Inc. stock2025 Volatility Report & AI Driven Stock Movement Reports - Newser

Dec 02, 2025

Is Seres Therapeutics Inc. stock dividend yield sustainablePortfolio Update Report & Growth Oriented Trade Recommendations - Newser

Dec 02, 2025

Is Seres Therapeutics Inc. stock positioned for long term growth2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser

Dec 02, 2025

Dec 01, 2025

Seres Therapeutics (MCRB) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 28, 2025

Volatility Watch: Why Seres Therapeutics Inc. stock is rated strong buyJuly 2025 Review & High Accuracy Trade Alerts - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

A look into Seres Therapeutics Inc (MCRB)’s deeper side - Setenews

Nov 27, 2025

Why Seres Therapeutics Inc. stock is rated strong buyMarket Performance Report & Fast Exit Strategy with Risk Control - BỘ NỘI VỤ

Nov 27, 2025

Is Seres Therapeutics Inc. stock affected by interest rate hikesTrade Entry Summary & Target Return Focused Picks - BỘ NỘI VỤ

Nov 27, 2025

Nov 24, 2025

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - The Manila Times

Nov 24, 2025

Seres Therapeutics (Nasdaq: MCRB) to join Piper Sandler 37th Annual Healthcare Conference - Stock Titan

Nov 24, 2025

Nov 22, 2025

Seres Therapeutics Inc Stock Analysis and ForecastHead and Shoulders Patterns & Big Gains Low Cost - earlytimes.in

Nov 22, 2025

Nov 21, 2025

What analysts say about Seres Therapeutics Inc stockMACD Histogram Signals & Budget Friendly Capital Growth - earlytimes.in

Nov 21, 2025

Should You Watch Rane Engine Valve Limited for Sector Rotation UpsideWeekly Market Snapshot & Free Stock Market Mentorship Programs - earlytimes.in

Nov 21, 2025

Can Poonawalla Fincorp Limited Deliver Consistent Free Cash FlowsMarket Depth Overview & Swing Trade Smarter With Data Insights - earlytimes.in

Nov 21, 2025